The Global Healthcare Distribution Market discusses the development of the strategy and the marketing prospects towards the worldwide distribution of healthcare products. The proper distribution of the health care products is the foundation of the life and death of the common people. Therefore, different manufacturers of the segment are required to ensure proper distribution for their products and services for the mass of the people.
The global healthcare distribution market accounted for approximately USD 718.50 billion in 2018 and is estimated to grow at a decent growth rate of more than 6 per cent during the forecast period [2020-2026]. Global healthcare distribution market involves moving and storing pharmaceutical goods from plants to wholesalers, hospitals and patients. Also, the global healthcare companies must adhere to these stringent public regulations concerning availability of pharmaceutical products in useable shapes to ensure their safety records. Further, growing incidences of chronic diseases and increasing uptake of bio-pharmaceuticals have led to the adoption of healthcare distribution services across the world during the forecast period.
According to the Pharmaceutical Research and Manufacturing Association (PhRMA), about half of the world’s R&D in pharmaceuticals, about USD 75 billion are conducted in the United States. The same source tells us that the biopharmaceuticals account for USD 1.3 trillion in economic output that represent 4 per cent of the total U.S. economy. This total economic impact includes USD 558 billion in revenue from biopharmaceuticals business. However, the pricing pressure has slowed down the growth of the market over the forecast period.
Region-wise, North America is the leading as well as significant region across the world in terms of market share owing to the presence of a large number of pharmaceutical and biotechnology companies and medical device manufacturers. Moreover, the dominance of healthcare distribution market is a result of the increasing government focus on generic drugs, incidence of chronic diseases, increasing demand for biologics and specialty drugs. On the other hand, the Asia-Pacific region is also anticipated to exhibit the highest growth rate over the forecast period. Factors, such as, the rising number of pharmaceutical and biotechnology companies, the implementation of stringent regulations to enhance the quality and reliability of pharmaceutical drugs and the expanding pharmaceutical industries would create lucrative growth prospects for the healthcare distribution market across the Asia-Pacific region.
The general trend for the global healthcare distribution market has also been changed with supports of the governmental policies in many countries. One of the major factors contributing towards the growth of the global healthcare distribution market includes the rise of chronic disease which needs to be checked and proper medications. In addition, rising prevalence of generic medicines and growth of medical device needs are propelling the global healthcare market. In addition, major emerging countries, like China and India, with significant rise in the population over the years, drastically found the increasing penetration of the biopharmaceuticals which also been a factor resulting in the growth of the global healthcare distribution market.
Some of the notable players operating in the global healthcare distribution market include: AmerisourceBergen Corporation, Cardinal Health, Inc. (US), McKesson Corporation, Morris and Dickson Co., LLC (US), KeySource Medical, Inc. (US), Owens & Minor, Inc. (US), Shanghai Pharmaceutical Group Co., Ltd, FFF Enterprises, Inc., Medline Industries, and CuraScript SD (US) among others.
Check the report description at: Global Healthcare Distribution Market Size, Trends & Analysis - Forecasts To 2026